156 related articles for article (PubMed ID: 38469106)
1. Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital.
Fisseha PY; Baye AM; Beyene MG; Makonnen E
Diabetes Metab Syndr Obes; 2024; 17():1157-1169. PubMed ID: 38469106
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Clinical Guidelines on STATIN Prescribing Among Diabetic Patients Aged 40-75 Years Old in a Primary Care Setting: A Cross-Sectional Study.
Abukhalil AD; Alyan M; AbuAita W; Al-Shami N; Naseef HA
Patient Prefer Adherence; 2022; 16():1855-1863. PubMed ID: 35942227
[TBL] [Abstract][Full Text] [Related]
3. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
[TBL] [Abstract][Full Text] [Related]
4. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States.
Decicco E; Peterson ED; Gupta A; Khalaf Gillard K; Sarnes E; Navar AM
Am J Prev Cardiol; 2023 Dec; 16():100604. PubMed ID: 38162437
[TBL] [Abstract][Full Text] [Related]
7. Association between statin therapy and outcomes in critically ill patients: a nested cohort study.
Al Harbi SA; Tamim HM; Arabi YM
BMC Clin Pharmacol; 2011 Aug; 11():12. PubMed ID: 21819615
[TBL] [Abstract][Full Text] [Related]
8. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
9. Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia.
Melaku EE; Ayele ET; Urgie BM; Ayidagnuhim GB; Hassen EM; Tefera AS
Vasc Health Risk Manag; 2023; 19():707-718. PubMed ID: 37954557
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Demoz GT; Berha AB; Alebachew Woldu M; Yifter H; Shibeshi W; Engidawork E
PLoS One; 2019; 14(10):e0222985. PubMed ID: 31574113
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study.
Abera RG; Demesse ES; Boko WD
BMC Endocr Disord; 2022 Mar; 22(1):54. PubMed ID: 35249547
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit.
Amor AJ; Ortega E; Giménez M; Cofán M; Blanco J; Pané A; Boswell L; Vinagre I; Esmatjes E; Conget I
Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):512-519. PubMed ID: 31000451
[TBL] [Abstract][Full Text] [Related]
14. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors.
Hsu CY; Chen WJ; Chen HM; Tsai HY; Hsiao FY
J Clin Pharm Ther; 2021 Apr; 46(2):415-423. PubMed ID: 33180353
[TBL] [Abstract][Full Text] [Related]
15. Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification.
Rana JS; Virani SS; Moffet HH; Liu JY; Coghlan LA; Vasadia J; Ballantyne CM; Karter AJ
Am J Med; 2022 May; 135(5):603-606. PubMed ID: 34861203
[TBL] [Abstract][Full Text] [Related]
16. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
17. Statin initiation and risk of incident kidney disease in patients with diabetes.
Zhou S; Su L; Xu R; Li Y; Chen R; Cao Y; Gao P; Zhang X; Luo F; Gao Q; An S; Cai W; Lin L; Xu H; Liu B; Weng J; Chunbo C; Liu H; Yang Q; Li H; Kong Y; Li G; Wan Q; Zha Y; Hu Y; Xu G; Shi Y; Zhou Y; Su G; Tang Y; Gong M; Xu X; Nie S
CMAJ; 2023 May; 195(21):E729-E738. PubMed ID: 37247880
[TBL] [Abstract][Full Text] [Related]
18. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS
Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004
[TBL] [Abstract][Full Text] [Related]
19. Role of Different Low-Density Lipoprotein-Lowering Medications on Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients With Diabetes Mellitus.
Saag JL; Gross D; Stirt D; Espina Rey A; Gros B
Cureus; 2023 Jun; 15(6):e40905. PubMed ID: 37492827
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
